Catalyst Pharmaceuticals Inc CPRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:44 AM EDT
16.68quote price arrow up+0.02 (+0.15%)
Volume
33,344
52 week range
11.09 - 17.50
Loading...
  • Open16.60
  • Day High16.70
  • Day Low16.53
  • Prev Close16.66
  • 52 Week High17.50
  • 52 Week High Date03/01/24
  • 52 Week Low11.09
  • 52 Week Low Date06/01/23

Key Stats

  • Market Cap1.969B
  • Shares Out118.01M
  • 10 Day Average Volume1.20M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-1.25

KEY STATS

  • Open16.60
  • Day High16.70
  • Day Low16.53
  • Prev Close16.66
  • 52 Week High17.50
  • 52 Week High Date03/01/24
  • 52 Week Low11.09
  • 52 Week Low Date06/01/23
  • Market Cap1.969B
  • Shares Out118.01M
  • 10 Day Average Volume1.20M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-1.25

RATIOS/PROFITABILITY

  • EPS (TTM)0.54
  • P/E (TTM)30.99
  • Fwd P/E (NTM)16.33
  • EBITDA (TTM)114.04M
  • ROE (TTM)14.55%
  • Revenue (TTM)411.347M
  • Gross Margin (TTM)86.74%
  • Net Margin (TTM)15.83%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Catalyst Pharmaceuticals Inc

 

Profile

MORE
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on developing and commercializing first-in-class medicines that address rare and difficult to treat diseases. Its flagship commercial product is FIRDAPSE (amifampridine) tablets 10 milligrams (mg), approved for the treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) for adults and for children ages six to seventeen. The Company is also marketing FYCOMPA (perampanel) CIII...
Patrick McEnany
Non-Executive Chairman of the Board
Richard Daly
Chief Executive Officer, Director
Steven Miller Ph.D.
Executive Vice President, Chief Operating and Scientific Officer
Michael Kalb
Chief Financial Officer, Executive Vice President
Jeffrey Del Carmen
Executive Vice President, Chief Commercial Officer
Alicia Grande CPA
Vice President, Treasurer
Address
355 ALHAMBRA CIRCLE, SUITE 801
Coral Gables, FL
33134
United States

Top Peers

SYMBOLLASTCHG%CHG
BEAM
Beam Therapeutics Inc
23.91-0.20-0.81%
VCYT
Veracyte Inc
23.41-0.14-0.59%
ZLAB
Zai Lab Ltd
19.83-1.02-4.89%
NVCR
Novocure Ltd
21.05UNCHUNCH
PTGX
Protagonist Therapeutics Inc
31.18-0.29-0.92%